On Nov. 1, 2018, City of Hope, and its affiliate, Translational Genomics Research Institute (TGen), announced a letter of intent to develop a state-of-the-art cell therapy manufacturing facility in the Phoenix Area, a move that would improve the speed at which stem cell research and cancer treatment is delivered.